A. Hingorani, T. Shah, M. Kumari, R. Sofat, and L. Smeeth, Translating genomics into improved healthcare, BMJ, vol.341, issue.nov05 1, pp.5945-21056961, 2010.
DOI : 10.1136/bmj.c5945

K. Malottki, M. Biswas, J. Deeks, R. Riley, C. Craddock et al., Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkers, BMJ Open, vol.4, issue.1, pp.4188-24468721, 2014.
DOI : 10.1136/bmjopen-2013-004188

N. Anderson, The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum, Clinical Chemistry, vol.56, issue.2, pp.177-185, 2010.
DOI : 10.1373/clinchem.2009.126706

P. Fournier, M. Drancourt, P. Colson, J. Rolain, L. Scola et al., Modern clinical microbiology: new challenges and solutions, Nature Reviews Microbiology, vol.459, issue.8, pp.574-585, 2013.
DOI : 10.1038/nature08182

A. Thrift, H. El-serag, and F. Kanwal, Global epidemiology and burden of HCV infection and HCV-related disease, Nature Reviews Gastroenterology & Hepatology, vol.62, issue.2, p.27924080, 2016.
DOI : 10.1002/hep.27969

J. Arends, P. A. Kracht, and A. Hoepelman, European Study Group for Viral Hepatitis (ESGVH) Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.22, pp.846-852, 2016.

W. De-bruijn, C. Ibáñez, P. Frisk, B. Pedersen, H. Alkan et al., Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future, Frontiers in Pharmacology, vol.41, issue.219, p.27516740, 0197.
DOI : 10.1111/apt.13081

D. Ge, J. Fellay, A. Thompson, J. Simon, K. Shianna et al., Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance, Nature, vol.18, issue.7262, pp.399-401, 2009.
DOI : 10.1038/nature08309

D. Thomas, C. Thio, M. Martin, Y. Qi, D. Ge et al., Genetic variation in IL28B and spontaneous clearance of hepatitis C virus, Nature, vol.119, issue.7265, pp.798-801, 2009.
DOI : 10.1002/hep.1840360706

E. Cariani, L. Roli, G. Missale, E. Villa, C. Ferrari et al., Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis, The Pharmacogenomics Journal, vol.125, issue.1, pp.18-29, 2016.
DOI : 10.1056/NEJMe1403619

A. St-john and C. Price, Existing and Emerging Technologies for Point-of-Care Testing, Clin Biochem Rev, vol.35, pp.155-167, 2014.

S. Raja, J. Ching, L. Xi, S. Hughes, R. Chang et al., Technology for Automated, Rapid, and Quantitative PCR or Reverse Transcription-PCR Clinical Testing, Clinical Chemistry, vol.51, issue.5, pp.882-890, 2005.
DOI : 10.1373/clinchem.2004.046474

C. Denkinger, S. Schumacher, C. Boehme, N. Dendukuri, M. Pai et al., Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis, European Respiratory Journal, vol.44, issue.2, pp.435-446, 2014.
DOI : 10.1183/09031936.00007814

D. Helb, M. Jones, E. Story, C. Boehme, E. Wallace et al., and Rifampin Resistance by Use of On-Demand, Near-Patient Technology, Journal of Clinical Microbiology, vol.48, issue.1, pp.229-237, 2010.
DOI : 10.1128/JCM.01463-09

M. Pepe, The Statistical Evaluation of Medical Tests for Classification and Prediction, 2004.

P. Castan, A. De-pablo, N. Fernández-romero, J. Rubio, B. Cobb et al., Point-of-Care System for Detection of Mycobacterium tuberculosis and Rifampin Resistance in Sputum Samples, Journal of Clinical Microbiology, vol.52, issue.2, pp.502-507, 2014.
DOI : 10.1128/JCM.02209-13

F. Tekola-ayele and C. Rotimi, Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges, Public Health Genomics, vol.18, issue.4, pp.242-247, 2015.
DOI : 10.1159/000433518

S. Kamal, Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents, Hepatic Medicine: Evidence and Research, vol.6, pp.61-77, 2014.
DOI : 10.2147/HMER.S41127

H. Rao, H. Li, H. Chen, J. Shang, Q. Xie et al., Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study, Journal of Gastroenterology and Hepatology, vol.62, issue.Suppl 2, pp.244-252, 2017.
DOI : 10.1093/cid/ciu077

A. Mangia, V. De-ledinghen, F. Bailly, J. Brahm, J. Keiss et al., IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study, SpringerPlus, vol.5, p.27917361, 1990.

M. Noureddin, E. Wright, H. Alter, S. Clark, E. Thomas et al., Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: A longitudinal analysis, Hepatology, vol.127, issue.5, pp.1548-1557, 2013.
DOI : 10.1053/j.gastro.2004.09.050

K. Chang, P. Tseng, Y. Wu, H. Hung, C. Huang et al., A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection, Clinical Gastroenterology and Hepatology, vol.13, issue.5, pp.1017-1024, 2015.
DOI : 10.1016/j.cgh.2014.10.035

M. Ibrahim, H. Salama, A. El-rahman, M. Dawood, R. Bader-el-din et al., Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients, Journal of Interferon & Cytokine Research, vol.36, issue.12, pp.698-705, 2016.
DOI : 10.1089/jir.2016.0042

A. Stättermayer and P. Ferenci, Effect of IL28B genotype on hepatitis B and C virus infection, Current Opinion in Virology, vol.14, pp.50-55, 2015.
DOI : 10.1016/j.coviro.2015.07.011

C. Tian, D. Hinds, B. Hromatka, A. Kiefer, N. Eriksson et al., Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections, bioRxiv, vol.https, 2016.

Y. Morán-auth, M. Penna-martinez, D. Perner, S. Susser, S. Wicker et al., IL28B gene variants and glucose metabolism in Type 2 Diabetes, Human Immunology, vol.77, issue.12, pp.1280-1283, 2016.
DOI : 10.1016/j.humimm.2016.09.007

J. Manry, G. Laval, E. Patin, S. Fornarino, Y. Itan et al., Evolutionary genetic dissection of human interferons, The Journal of Experimental Medicine, vol.30, issue.13, pp.2747-2759, 2011.
DOI : 10.1111/j.1600-065X.2008.00698.x

A. Price, D. Tedesco, M. Prasad, K. Workowski, C. Walker et al., genotype, Proceedings of the National Academy of Sciences, vol.68, issue.6, pp.10678-10683, 2016.
DOI : 10.1128/JVI.76.11.5532-5539.2002